Ritlecitinib Tosylate

Ritlecitinib Tosylate
CAS:2192215-81-7
MF:C22H27N5O4S
MW:457.55
EINECS:201-058-9
Advantage:
Sample is Available
High purity, Top quality and best price
COA, HPLC, MSDS available
Certificate: ISO,cGMP,CTC,SGS,CQC
Place of Origin: Shandong, China

Send Inquiry

Ritlecitinib-Tosylate-2192215-81-7COA(J-RI17-202503002).pdf

Description

Ritlecitinib Tosylate information

Ritlecitinib Tosylate is an active pharmaceutical intermediate with selective kinase inhibition. It is widely used in the development of immunological and dermatological drugs. As the tosylate salt form of Ritlecitinib, it offers better stability and handling performance in pharmaceutical research and formulation.

Ritlecitinib Tosylate as raw material is involved in the chemical synthesis of pharmaceutical raw materials, which is used for laboratory research.

Ritlecitinib Tosylate powder

Parameters

Product Name:	Ritlecitinib Tosylate
Chemical Name:	2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-, 4-methylbenzenesulfonate (1:1)
CAS:	2192215-81-7
MF:	C22H27N5O4S
MW:	457.55
Application:	Chemical synthesis, pharmaceutical intermediates
Feature:	White powder, inhibitor raw material
EINECS:	201-058-9
Mol File:	2192215-81-7.mol

Certificate of Analysis

Product Name: 2-Propen-1-one,1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-, 4-methylbenzenesulfonate(1:1)
CAS No.:2192215-81-7
Batch No.:J-RI17-202407001
Mfg Date:20240718
Retest Date:202606
Storage:Sealed,keep away from light.
Perform Standard: Enterprise Standard
Test Items	Specifications	Test Results
Appearance	White,off-white to light yellow amorphous solid,free from visible foreign matter	Off-white solid,free from visible foreign matter
Identification	1H-NMR	Conforms to structure
Residual solvent content by GC	≤2.0%	1.49%
Water	≤0.2%	0.13%
Related substances	Max single impurity≤0.5%	<0.5%
RP-HPLC purity	≥98.00%	99.22%
Storage temperature	-15~-25℃
Conclusion:Conforms to Enterprise standard